Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14347
Title: | Phytochemical and biological activity studies of the Bhutanese medicinal plant corydalis crispa |
Authors: | Wangchuk P. Keller P.A. Pyne S.G. Sastraruji T. Taweechotipatr M. Rattanajak R. Tonsomboon A. Kamchonwongpaisan S. |
Keywords: | 13 oxocryptopine 13 oxoprotopine amoxicillin amphotericin B antibiotic agent antiflagellate agent antifungal agent antiinflammatory agent antimalarial agent antitrypanosomal agent bicuculline chloroquine coreximine Corydalis crispa extract cycloguanil dexamethasone galantamine ochrobirine pb 113 plant extract plant medicinal product protopine pyrimethamine rheagenine sibiricine stylopine unclassified drug vancomycin antibacterial activity antifungal activity antiinflammatory activity antiprotozoal activity article Bhutan biological activity controlled study Corydalis crispa cytokine production drug isolation drug mechanism drug screening drug structure enzyme inhibition nonhuman nuclear magnetic resonance Papaveraceae phytochemistry Plasmodium falciparum Corydalis Fumariaceae Plasmodium falciparum |
Issue Date: | 2012 |
Abstract: | The chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated for the first time. The phytochemical study resulted in the isolation of nine known isoquinoline alkaloids: protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the first time. Crude extracts exhibited significant anti-inflammatory (p<0.01) activity against TNF-α production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4 and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 (multidrug resistant strain) are reported here for the first time. Stylopine (4) did not show antimalarial activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis for the use of this plant in Bhutanese traditional medicine, either individually or in combination with other medicinal ingredients to treat a broad range of disorders. This study also identified compound 5 as potential new antimalarial lead compound. |
URI: | https://ir.swu.ac.th/jspui/handle/123456789/14347 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84861505544&doi=10.1177%2f1934578x1200700507&partnerID=40&md5=32ca02c41f971064f9320f03e533e056 |
ISSN: | 1934578X |
Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.